FDA Approves Generic HIV Prevention Shot for Low-Income Countries at $40 Annual Cost
The U.S. Food and Drug Administration granted tentative approval on Monday to a generic version of lenacapavir, the twice-yearly injection that prevents HIV. The drug is made by Dr. Reddy's Laboratories of India and is meant for 120 low- and middle-income countries at $40 per person per year.
READ STORY
